Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1)
辅助高剂量褪黑素治疗原发性进展型多发性硬化症患者（接受奥瑞珠单抗治疗）的肝脏安全性：一项 I/II 期随机临床试验（MELATOMS-1）的肝毒性结果
期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-025-01261-w
Bejarano, Ignacio; Jiménez-Jorge, Silvia; Lobo-Acosta, María Ángeles; Álvarez-López, Ana Isabel; Rosso-Fernández, Clara María; López-Ruiz, Rocío; Eichau, Sara; Ruiz-Peña, Juan Luis; Géniz, María Ángeles; Ampuero, Javier; Ponce-España, Eduardo; Merino-Bohorquez, Vicente; Cameán, Manuel; García-Sánchez, María Isabel; Izquierdo, Guillermo; Guerrero, Juan Miguel; Romero-Gómez, Manuel; Lardone, Patricia Judith; Carrillo-Vico, Antonio
